Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($) |
Oct. 31, 2022 |
Jul. 31, 2022 |
Jul. 31, 2021 |
|---|---|---|---|
| Balance Sheet Details | |||
| Research and development costs | $ 3,402,401 | $ 3,210,627 | $ 4,206,926 |
| Professional services fees | 1,319,890 | 877,411 | 1,229,040 |
| Other | 80,165 | 120,184 | 125,679 |
| Total | $ 4,802,456 | $ 4,208,222 | $ 5,561,645 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Research and development costs. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|